Deborah H. Telman - Jan 25, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: EVP, Corporate Affairs & GC
Signature: /s/ Edward S. Son by Power of Attorney for Deborah H. Telman
Stock symbol: GILD
Transactions as of: Jan 25, 2025
Transactions value $: -$17,404
Form type: 4
Date filed: 1/27/2025, 05:47 PM
Previous filing: Dec 11, 2024
Next filing: Feb 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+515	+2.42%		21.8K	Jan 25, 2025	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$17.4K	-187	-0.86%	$93.07	21.6K	Jan 25, 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-515	-1.81%		27.9K	Jan 25, 2025	Common Stock	515		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.